Passions

Fitness

Playing guitar

Learning to cook

Admissions and credentials

Virginia

Experience

MapLight Therapeutics Closes Oversubscribed $372.5 Million Series D

July 28, 2025

Cooley advised MapLight Therapeutics, a clinical-stage biopharmaceutical company developing targeted, novel therapies for patients with central nervous system disorders, on its oversubscribed $372.5 million Series D financing.

Read more

Related contacts

Christian Plaza
Partner, Reston
Matthew Schwee
Partner, Reston
David Brinton
Associate, Washington, DC
Heather McShea
Associate, Washington, DC
Mark Ballantyne
Partner, Reston
Michael Egan
Partner, Washington, DC
Jim Fulton
Partner, New York
Brendan Hughes
Co-Partner in Charge – Washington, DC, Washington, DC
Christopher Kimball
Partner, Washington, DC
Dr. Michael Tuscan
Partner, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Elise Robinson
Associate, Reston
Patrick Sharma
Associate, Santa Monica
Sarah Swain
Associate, Washington, DC
Dr. Jason Valentine
Associate, Washington, DC
Drue Anne Koons
Paralegal Specialist, San Diego
Kevin Gurley
Quantitative Analyst, New York

Related Practices & Industries

Memberships and affiliations

American Bar Association (ABA)

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.